These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35280499)

  • 1. Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus.
    He X; Sun J; Liu C; Yu X; Li H; Zhang W; Li Y; Geng Y; Wang Z
    Diabetes Metab Syndr Obes; 2022; 15():755-765. PubMed ID: 35280499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals.
    Han S; Chen M; Cheng P; Zhang Z; Lu Y; Xu Y; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():1018093. PubMed ID: 36339429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis.
    Wang Y; Zhao J; Qin Y; Yu Z; Zhang Y; Ning X; Sun S
    Front Immunol; 2022; 13():908219. PubMed ID: 35784273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome-metabolome combined validation in a mouse model.
    Shang J; Cui W; Guo R; Zhang Y; Wang P; Yu W; Zheng X; Wang T; Dong Y; Zhao J; Ding S; Xiao J; Ren Z; Zhao Z
    Front Endocrinol (Lausanne); 2022; 13():964389. PubMed ID: 36601003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice.
    Wang P; Guo R; Bai X; Cui W; Zhang Y; Li H; Shang J; Zhao Z
    Front Endocrinol (Lausanne); 2022; 13():1034818. PubMed ID: 36589853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.
    Chen R; Zhu D; Yang R; Wu Z; Xu N; Chen F; Zhang S; Chen H; Li M; Hou K
    Ann Transl Med; 2022 Jul; 10(13):750. PubMed ID: 35957707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease.
    Mao ZH; Gao ZX; Liu DW; Liu ZS; Wu P
    Front Immunol; 2023; 14():1124704. PubMed ID: 36742307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the Gut Microbiota in Multiple System Atrophy Patients.
    Wan L; Zhou X; Wang C; Chen Z; Peng H; Hou X; Peng Y; Wang P; Li T; Yuan H; Shi Y; Hou X; Xu K; Xie Y; He L; Xia K; Tang B; Jiang H
    Front Neurosci; 2019; 13():1102. PubMed ID: 31680836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.
    Zhang Q; Zhang Y; Zeng L; Chen G; Zhang L; Liu M; Sheng H; Hu X; Su J; Zhang D; Lu F; Liu X; Zhang L
    Front Pharmacol; 2021; 12():757508. PubMed ID: 34899312
    [No Abstract]   [Full Text] [Related]  

  • 10. Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice.
    Wu J; Chen Y; Yang H; Gu L; Ni Z; Mou S; Shen J; Che X
    Front Endocrinol (Lausanne); 2023; 14():1026040. PubMed ID: 36777358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives.
    Lin JR; Wang ZT; Sun JJ; Yang YY; Li XX; Wang XR; Shi Y; Zhu YY; Wang RT; Wang MN; Xie FY; Wei P; Liao ZH
    World J Diabetes; 2022 Apr; 13(4):308-318. PubMed ID: 35582668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy.
    Zhang L; Wang Z; Zhang X; Zhao L; Chu J; Li H; Sun W; Yang C; Wang H; Dai W; Yan S; Chen X; Xu D
    Microbiol Spectr; 2022 Aug; 10(4):e0032422. PubMed ID: 35863004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of gut microbiome in patients with type 2 diabetes mellitus who had undergone cholecystectomy.
    Wei B; Wang Y; Xiang S; Jiang Y; Chen R; Hu N
    Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E113-E121. PubMed ID: 33166187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease.
    Gao Y; Yang R; Guo L; Wang Y; Liu WJ; Ai S; Woon TH; Wang Z; Zhai Y; Wang Z; Peng L
    Front Med (Lausanne); 2021; 8():719950. PubMed ID: 34604258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective.
    Das S; Gnanasambandan R
    Life Sci; 2023 Mar; 316():121414. PubMed ID: 36682521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease.
    Zhang B; Wan Y; Zhou X; Zhang H; Zhao H; Ma L; Dong X; Yan M; Zhao T; Li P
    Front Pharmacol; 2022; 13():872988. PubMed ID: 35548353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated 16S rRNA Sequencing, Metagenomics, and Metabolomics to Characterize Gut Microbial Composition, Function, and Fecal Metabolic Phenotype in Non-obese Type 2 Diabetic Goto-Kakizaki Rats.
    Peng W; Huang J; Yang J; Zhang Z; Yu R; Fayyaz S; Zhang S; Qin YH
    Front Microbiol; 2019; 10():3141. PubMed ID: 32038574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting gut microbiota: a potential promising therapy for diabetic kidney disease.
    Chen Z; Zhu S; Xu G
    Am J Transl Res; 2016; 8(10):4009-4016. PubMed ID: 27829988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moutan Cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats.
    Zhang M; Yang L; Zhu M; Yang B; Yang Y; Jia X; Feng L
    Int J Biol Macromol; 2022 May; 206():849-860. PubMed ID: 35307460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
    Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
    Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.